
Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Discover a CDMO with a science-led approach and unparalleled project delivery.
As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness.
Through our science-led approach we align to your drug development needs from pre-clinical to late phase manufacture, across oral solid dosage forms, liquids, semi-solids, nasal and inhaled products.
Our team support you at each stage of your drug program lifecycle from pre-clinical to market.
Our CDMO services include formulation development, phase 1, phase 2 and phase 3 clinical supply, process scale-up and optimisation, quality control, analytical development and validation, and registration activities.
Our project teams are made up of subject experts from across our business. With oversight from an Executive Leadership Team member on every project, our approach ensures you can have open and transparent conversations, enabling quick decision-making and collaboration across our business to ensure your project’s success.
Our award-winning 50,000 sqft development and manufacturing facility, Trent Gateway, enables our teams to be flexible and nimble so that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA
If you’re looking to work with a CDMO that can support your product from pre-clinical development to market, then we’re here to help.
Download our brochure to learn more about our capabilities.
Driven by experts, led by science
Integrated CDMO services
By Development Stage
Development Platforms
Route of delivery
About Us
Our Approach
Events
Resources
Policies
Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA, UK. Phone: +44 (0) 115 855 7050 Email: contact@upperton.com
Copyright © 2025 Upperton Limited. Registration number: 03833301. Registered office address: Albert Einstein Centre, Nottingham Science Park, Nottingham, NG7 2TN. Registered in England. All rights reserved.
Speak with our team of experts and set up a discovery call to discuss your project in more detail.